The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Clinics in Liver Disease · 2023
DOI: 10.1016/j.cld.2023.01.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Liver Disease, 2023. Verfasst von Aaron Yeoh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Bariatric Surgery, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Disease spectrum varies from steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Currently, there are no approved medical therapies, and weight loss through lifestyle modifications remains a mainstay of therapy. Bariatric surgery is the most effective therapy for weight loss and has been shown to improve liver histology. Recently, endoscopic bariatric metabolic therapies have also emerged as effective treatments for patients with obesity and NAFLD. This review summarizes the role of bariatric surgery and endoscopic therapies in the management of patients with NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, CA, USA; Gastroenterology Section, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA, USA.
- University of South Dakota Sanford School of Medicine; Avera Medical Group Liver Disease and Transplant Institute, Avera McKennan University Hospital, Clinical Research Affairs Avera Transplant Institute, 1315 South Cli…
Zitieren
APA
Yeoh, A., Wong, R., & Singal, A. K. (2023). The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis. Clinics in Liver Disease. https://doi.org/10.1016/j.cld.2023.01.009
Vancouver
Yeoh A, Wong R, Singal AK. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis. Clinics in Liver Disease. 2023. doi:10.1016/j.cld.2023.01.009
BibTeX
@article{Yeoh2023,
author = {Yeoh, Aaron and Wong, Robert and Singal, Ashwani K},
title = {The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis},
journal = {Clinics in Liver Disease},
year = {2023},
doi = {10.1016/j.cld.2023.01.009}
}
EUVIMED